Comparative activity of ceftobiprole against coagulase-negative staphylococci from the BSAC Bacteraemia Surveillance Programme, 2013–2015

por Henriksen, Anne Santerre, Smart, Jennifer, Hamed, Kamal
Publicado 2018

1043. Activity of Mecillinam Against Enterobacterales Isolates Collected From Patients With Urinary Tract Infections (UTIs) in the USA During 2019

por Hawser, Stephen, Morrissey, Ian, Henriksen, Anne Santerre
Publicado 2021

1433. Impact of 2019 US Food and Drug Administration (FDA) Guidance on Developing Drugs for Urinary Tract Infection (UTI) on the Perceived Efficacy of Antibiotics for the Treatment...

por Henriksen, Anne Santerre, Nicolle, Lindsay, Das, Anita F
Publicado 2021

1428. Increased Consumption of Pivmecillinam in Primary Care for Uncomplicated Urinary Tract Infection (uUTI) Is Not Associated With Increased Resistance Rates

por Larsen, Anders Rhod, Henriksen, Anne Santerre, Frimodt-Møller, Niels
Publicado 2021

US-Focused Conceptual Health Care Decision-Analytic Models Examining the Value of Pivmecillinam Relative to Current Standard-of-Care Agents Among Adult Patients With Uncomplicated...

por Lodise, Thomas P, Henriksen, Anne Santerre, Hadley, Thomas, Patel, Nimish
Publicado 2021

Erratum to: In vitro activity of cefiderocol and comparators against isolates of Gram-negative pathogens from a range of infection sources: SIDERO-WT-2014–2018 studies in France

por Naas, Thierry, Lina, Gerard, Henriksen, Anne Santerre, Longshaw, Christopher, Jehl, Francois
Publicado 2021

1617. Mecillinam susceptibility against Enterobacterales isolated from urinary tract infections from US patients in 2018

por Hawser, Stephen, Morrissey, Ian, Charrier, Cedric, De Piano, Cyntia, Alexander, Morton, Henriksen, Anne Santerre
Publicado 2020